HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Orimo Selected Research

3-Iodobenzylguanidine (Iobenguane)

3/2016[Dementia with Lewy bodies].
1/2016(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
9/2015Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease.
4/2015[Differential diagnosis of dementia with lewy bodies].
4/2013Lewy pathology in an autopsy case of FTLD-MND with reduced cardiac MIBG uptake and depletion of cardiac sympathetic fibers.
1/2013[Initial diagnosis of Parkinson's disease - neuroradiological diagnosis].
4/2012[The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].
1/2012Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG.
11/2008[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
3/2008Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Orimo Research Topics

Disease

18Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2003
10Dementia (Dementias)
01/2022 - 06/2005
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 06/2005
7Lewy Body Disease (Lewy Body Dementia)
01/2016 - 06/2005
5Parkinsonian Disorders (Parkinsonism)
01/2017 - 10/2005
4Multiple System Atrophy
07/2010 - 06/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
08/2020 - 06/2005
3Movement Disorders (Movement Disorder)
08/2019 - 01/2008
3Atrophy
03/2016 - 01/2012
2Synucleinopathies
08/2018 - 01/2016
2Pure Autonomic Failure
01/2016 - 04/2012
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2012 - 06/2005
1Spastic Paraparesis
07/2021
1Oculodentodigital Dysplasia
07/2021
1Encephalitis (Encephalitis, Rasmussen)
03/2021
1Miller Fisher Syndrome (Fisher Syndrome)
03/2021
1Ataxia (Dyssynergia)
03/2021
1Neuronal intranuclear inclusion disease
08/2020
1Myasthenia Gravis
03/2020
1Thymoma (Thymic Carcinoma)
03/2020
1Pruritus (Itching)
01/2020
1Meningitis
09/2019
1Adult-Onset Still's Disease
09/2019
1Bacterial Meningitis
09/2019
1Pyloric Stenosis
01/2015
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
01/2015
1Infarction (Infarctions)
01/2015
1Diplopia (Double Vision)
01/2015
1Diabetes Mellitus
01/2015
1Alcoholism (Alcohol Abuse)
01/2015
1Brain Diseases (Brain Disorder)
09/2014
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2014
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
04/2013
1Ophthalmoplegia (External Ophthalmoplegia)
01/2012
1Disease Progression
03/2008
1Nervous System Diseases (Neurological Disorders)
01/2008
1Heart Diseases (Heart Disease)
01/2008
1Corticobasal Degeneration
01/2003

Drug/Important Bio-Agent (IBA)

183-Iodobenzylguanidine (Iobenguane)IBA
03/2016 - 01/2003
4Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2017 - 01/2013
4Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2016 - 06/2005
4alpha-SynucleinIBA
07/2010 - 09/2005
3AntibodiesIBA
03/2021 - 01/2007
3Biomarkers (Surrogate Marker)IBA
08/2018 - 01/2007
2SynucleinsIBA
01/2022 - 08/2018
2Levodopa (L Dopa)FDA LinkGeneric
01/2012 - 10/2005
1disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA
07/2021
1BaclofenFDA LinkGeneric
07/2021
1Immunoglobulin G (IgG)IBA
03/2021
1GangliosidesIBA
03/2021
1UbiquitinIBA
08/2020
1Cholinergic ReceptorsIBA
03/2020
1Prednisone (Sone)FDA LinkGeneric
03/2020
1rotigotineFDA Link
01/2020
1Dopamine Agonists (Dopamine Agonist)IBA
01/2020
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
12/2019
1SteroidsIBA
09/2019
1istradefyllineIBA
08/2019
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
08/2019
1Iodine-123IBA
11/2018
1Thiamine (Aneurin)FDA Link
01/2015
1Insulin (Novolin)FDA Link
01/2015
1IronIBA
09/2014
1PrionsIBA
01/2014
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2012
1thiazin redIBA
01/2012

Therapy/Procedure

5Sympathectomy (Sympathectomies)
11/2008 - 01/2005
3Therapeutics
07/2021 - 01/2015
1Thymectomy
03/2020
1Plasmapheresis
03/2020
1Transdermal Patch
01/2020
1Gastrostomy
02/2012